Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Negative signals for adenomyomatosis of the gallbladder upon diffusion-weighted whole body imaging with background body signal suppression/T2-weighted image fusion analysis.
Tomizawa M, Shinozaki F, Fugo K, Sunaoshi T, Sugiyama E, Kano D, Shite M, Haga R, Fukamizu Y, Kagayama S, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N. Tomizawa M, et al. Among authors: fugo k. Exp Ther Med. 2016 May;11(5):1777-1780. doi: 10.3892/etm.2016.3126. Epub 2016 Mar 2. Exp Ther Med. 2016. PMID: 27168802 Free PMC article.
Diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion of gastrointestinal cancers.
Tomizawa M, Shinozaki F, Fugo K, Sunaoshi T, Kano D, Tanaka S, Ozaki A, Sugiyama E, Shite M, Haga R, Baba A, Fukamizu Y, Fujita T, Kagayama S, Hasegawa R, Togawa A, Shirai Y, Ichiki N, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N. Tomizawa M, et al. Among authors: fugo k. Mol Clin Oncol. 2016 Jul;5(1):44-48. doi: 10.3892/mco.2016.897. Epub 2016 May 11. Mol Clin Oncol. 2016. PMID: 27330763 Free PMC article.
Diffusion-weighted whole-body imaging with background body signal suppression/T2 image fusion and positron emission tomography/computed tomography of upper gastrointestinal cancers.
Tomizawa M, Shinozaki F, Uchida Y, Uchiyama K, Fugo K, Sunaoshi T, Ozaki A, Sugiyama E, Baba A, Fukamizu Y, Kagayama S, Hasegawa R, Shirai Y, Oshima Y, Koike N, Toshimitsu Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N. Tomizawa M, et al. Among authors: fugo k. Abdom Imaging. 2015 Oct;40(8):3012-9. doi: 10.1007/s00261-015-0545-2. Abdom Imaging. 2015. PMID: 26350283
Anti-mitochondrial M2 antibody-positive autoimmune hepatitis.
Tomizawa M, Shinozaki F, Fugo K, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N. Tomizawa M, et al. Among authors: fugo k. Exp Ther Med. 2015 Oct;10(4):1419-1422. doi: 10.3892/etm.2015.2694. Epub 2015 Aug 20. Exp Ther Med. 2015. PMID: 26622500 Free PMC article.
Unenhanced areas revealed by contrast-enhanced abdominal ultrasonography with Sonazoid™ potentially correspond to colorectal cancer.
Tomizawa M, Togashi M, Shinozaki F, Hasegawa R, Shirai Y, Noritake M, Matsuoka Y, Kainuma H, Iwasaki Y, Fugo K, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N. Tomizawa M, et al. Among authors: fugo k. Exp Ther Med. 2016 Dec;12(6):4012-4016. doi: 10.3892/etm.2016.3868. Epub 2016 Nov 3. Exp Ther Med. 2016. PMID: 28105132 Free PMC article.
44 results